Project Grant R03AI185412

Award Date 6/17/24
Completion Date 4/30/26
Dollars Obligated $380K
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Sunnyvale, CA 94085, USA
Similar Awards
This Project Grant award of $673,729.00 from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) will support research to define the impact of dietary conjugated linoleic acid (CLA) on the formation of nitro-fatty acids (NO2-FAs) in skin tissues and establish their protective effects on psoriasis. The University of Pittsburgh will pursue three specific aims: 1) Defining the...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $597,542 to Emory University to study the metabolic and epigenetic regulation of skin-resident regulatory T cells (Tregs). The key goals of this 5-year research project are to: 1) dissect how glycolysis promotes the homeostasis of skin Tregs and delineate hypoxia as a key environmental signal driving this...
This federal Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), provides $343,904 to The Regents of the University of California, San Francisco to investigate transcriptional abnormalities in skin-resident T cells as potential biomarkers for atopic dermatitis in Asian and Hispanic genetic backgrounds. The research aims to validate an abnormal atopic T...
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded a $628,968 project grant (CFDA 93.846 - Arthritis, Musculoskeletal and Skin Diseases Research) to The Regents of the University of California, San Francisco (UCSF) to define and treat genetic abnormalities in psoriasis/atopic dermatitis-overlap dermatoses. The project aims to use high-resolution, quantitative biomarkers to understand the etiology of these "PSO-AD" rashes and determine if they...
This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research) provides $516,648 to The Leland Stanford Junior University (Stanford University) to conduct research on understanding how microbially-derived metabolites regulate host gut inflammation. The key objectives of this 2.5-year project are to: 1) determine the regulatory role of these microbial metabolites on the host immune...
This Project Grant award of $141,609 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) will support research to investigate how skin commensal bacteria interact with the immune system to promote tolerance in early life. The primary focus is on understanding how Toll-like receptor 2 (TLR2) sensing of modified ligands on Staphylococcus species supports the induction of commensal-specific regulatory T...
This Project Grant award of $405,350.00 was provided by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). The research aims to characterize lipid droplets in macrophage subsets and determine if manipulating lipid droplet content can shift macrophage function, with the goal of uncovering new therapeutic targets for systemic lupus erythematosus (SLE). The award recipient is The...
This federal Project Grant award of $242,310 from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), supports research to uncover how allergic "type 2" skin inflammation impacts the long-term functional responsiveness and epigenetic state of epithelial stem cells. The award recipient, Rockefeller University, will use thymic stromal lymphopoietin (TSLP) as a driver to...
This Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) provides $295,294 to Biotherapeutics, Inc. for the development of a novel first-in-class topical immunoregulatory therapeutic for the treatment of plaque psoriasis. The key objectives are to: 1) evaluate the permeability and long-term stability of the topical drug product formulation, 2) compare the...
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded a $172,700 Project Grant (CFDA 93.846 - Arthritis, Musculoskeletal and Skin Diseases Research) to the University of California, Irvine. This grant will fund the development and characterization of recombinant, cell-penetrating botulinum protease variants that can inhibit the release of neuropeptides and cytokines in neurons and immune cells, respectively. The goal is to create a new topical therapeutic...

METABOLOMICS AND TRANSCRIPTOMICS ANALYSES OF CELL-SPECIFIC REGULATION OF FATTY ACID SYNTHESIS AND METABOLIC REPROGRAMMING IN SKIN INFLAMMATION - ABSTRACT CELL METABOLISM PLAYS A CRUCIAL ROLE IN REGULATING THE ACTIVATION OF IMMUNE CELLS IN HOST DEFENSE TO INFECTION AND THE DEVELOPMENT OF INFLAMMATORY DISEASES. DIFFERENT ASPECTS OF CELL METABOLISM CAN REGULATE THE ACTIVATION OF IMMUNE CELLS TOWARD PRO-INFLAMMATORY OR ANTI-INFLAMMATORY RESPONSES. THUS, PROPER METABOLIC REPROGRAMMING IN IMMUNE CELLS IS CRUCIAL TO MAINTAINING ACTIVE IMMUNITY, WHILE ABERRANT REGULATION OF IMMUNE CELL METABOLISM CAN CONTRIBUTE TO DISEASE DEVELOPMENT. EMERGING EVIDENCE INDICATES THAT FATTY ACID SYNTHESIS PLAYS A CRUCIAL ROLE IN IMMUNITY AND DISEASE DEVELOPMENT SINCE FATTY ACIDS ARE KEY COMPONENTS OF CELLULAR PROCESSES INCLUDING MEMBRANE FUNCTION, SIGNAL TRANSDUCTION, AND ENERGY GENERATION. RECENT STUDIES SUGGEST THAT FATTY ACID SYNTHESIS IS CLOSELY ASSOCIATED WITH A PRO-INFLAMMATORY PHENOTYPE OF IMMUNE CELLS AND THE DEVELOPMENT OF SOME INFLAMMATORY DISEASES, IMPLYING THAT MODIFICATIONS IN FATTY ACID SYNTHESIS CAN BE USED AS A THERAPEUTIC STRATEGY FOR THE TREATMENT OF METABOLIC AND INFLAMMATORY DISEASES. WE FOUND THAT INHIBITION OF FATTY ACID SYNTHASE (FASN), THE CENTRAL ENZYME OF FATTY ACID SYNTHESIS, SIGNIFICANTLY ALLEVIATED THE PATHOLOGY OF IMIQUIMOD (IMQ)-INDUCED PSORIASIS-LIKE SKIN INFLAMMATION IN MICE BY REDUCING THE INFLAMMATORY RESPONSES IN IMMUNE CELLS AND SKIN. HOWEVER, THE DETAILED MECHANISM OF FATTY ACID SYNTHESIS-DEPENDENT SKIN INFLAMMATION IS NOT CLEAR DUE TO THE SYSTEMIC AND NON-CELL TYPE-SPECIFIC EFFECTS OF THE INHIBITORS. ADDITIONALLY, IT IS NOT CLEAR HOW CELL METABOLISM IN IMMUNE CELLS OR SKIN TISSUES CHANGES DURING THE DEVELOPMENT OF SKIN INFLAMMATION AND HOW THE INHIBITION OF FATTY ACID SYNTHESIS AFFECTS METABOLIC REPROGRAMING. TO UNDERSTAND THE ROLE OF FATTY ACID SYNTHESIS IN CELLS AND TISSUES IN SKIN INFLAMMATION, WE WILL GENERATE CELL- SPECIFIC FASN-DEFICIENT MICE AND EXAMINE HOW INHIBITION OF FATTY ACID SYNTHESIS AFFECTS THE OTHER METABOLIC PATHWAYS IN IMMUNE CELLS AND SKIN TISSUES. WE WILL BE ABLE TO BETTER UNDERSTAND THE PREVIOUSLY UNIDENTIFIED ROLE AND REGULATORY MECHANISM OF FATTY ACID SYNTHESIS IN IMMUNE CELLS AND PSORIASIS. THE PROPOSED STUDIES WILL HELP US BETTER UNDERSTAND THE METABOLIC REGULATION OF IMMUNE CELLS AND WILL LEAD TO NOVEL INSIGHTS INTO FATTY ACID SYNTHESIS AND IMMUNE FUNCTION IN THE CONTEXT OF SKIN DISEASE. BY IDENTIFYING PREVIOUSLY UNCHARACTERIZED DISTINCT AND SPECIFIC PATHWAYS REGULATED BY FATTY ACID SYNTHESIS, WE WILL BE ABLE TO EXPAND OUR KNOWLEDGE TO OTHER INFLAMMATORY DISEASES SUCH AS ARTHRITIS AND INFLAMMATORY BOWEL DISEASES, WHICH WILL FURTHER GUIDE US IN DEVELOPING NOVEL TARGETED THERAPIES FOR TREATING AUTOIMMUNE DISEASES, METABOLIC DISORDERS, AND INFLAMMATORY DISORDERS.

Posted 6/17/24, 12:00 AM